Non Invasive Blood Test To Diagnose Acute Rejection After Kidney Transplantation

NCT02424227 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 401

Last updated 2018-12-17

No results posted yet for this study

Summary

This is a prospective, multicenter, observational study of kidney transplant subjects where blood specimens, intended for dd-cfDNA and other future research purposes, will be drawn after transplant

Conditions

  • Kidney Transplant Recipients

Sponsors & Collaborators

  • CareDx

    lead INDUSTRY

Principal Investigators

  • James Yee, MD · CareDx

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2018-08-30
Completion
2019-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02424227 on ClinicalTrials.gov